(Q44646549)

English

Effect of bupropion on CYP2B6 and CYP3A4 catalytic activity, immunoreactive protein and mRNA levels in primary human hepatocytes: comparison with rifampicin

scientific article published in September 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Effect of bupropion on CYP2B6 and CYP3A4 catalytic activity, immunoreactive protein and mRNA levels in primary human hepatocytes: comparison with rifampicin (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

David J. Greenblatt

6

object named as

David J Greenblatt

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Lisa L. von Moltke

5

object named as

Lisa L von Moltke

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1

object named as

Leah M Hesse

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Daesety Vishnuvardhan

3

object named as

Daesety Vishnuvardhan

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

Yumiko Sakai

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1229-1239

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Rifampin drastically reduces plasma concentrations and effects of oral midazolam.

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Bupropion in depression. II. The role of metabolites in clinical outcome

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture.

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers.

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog.

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5.

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

The disposition of bupropion and its metabolites in healthy male volunteers after single and multiple doses

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

In vitro approaches to predicting drug interactions in vivo.

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Application of QuantiGene nucleic acid quantification technology for high throughput screening

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Pharmacological significance of the species differences in bupropion metabolism

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Use of single sample clearance estimates of cytochrome P450 substrates to characterize human hepatic CYP status in vivo

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Determination of bupropion and its major basic metabolites in plasma by liquid chromatography with dual-wavelength ultraviolet detection

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

A prospective safety surveillance study for bupropion sustained-release in the treatment of depression.

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Ethanol and isopentanol increase CYP3A and CYP2E in primary cultures of human hepatocytes

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Stability of bupropion and its major metabolites in human plasma

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Triazolam is ineffective in patients taking rifampin

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

A branched DNA signal amplification assay to quantitate messenger RNA of human uncoupling proteins 1, 2, and 3

1 reference

https://api.crossref.org/works/10.1211%2F0022357021657

21 January 2018

Identifiers

10.1211/0022357021657

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44646549&oldid=2030814742"